HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405
CONCLUSION: HER2 gene expression was prognostic and predictive in CALGB/SWOG 80405. HER2 tumor expression may inform treatment selection for patients with low HER2 favoring bevacizumab- versus cetuximab-based therapies.PMID:38457761 | DOI:10.1200/JCO.23.01507
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Francesca Battaglin Fang-Shu Ou Xueping Qu Howard S Hochster Donna Niedzwiecki Richard M Goldberg Robert J Mayer Karam Ashouri Tyler J Zemla Charles D Blanke Alan P Venook Omar Kabbarah Heinz-Josef Lenz Federico Innocenti Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Erbitux | Genetics | HER2 | Leukemia | Nanotechnology